Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
1 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
29
Lobbying Costs over the years
-
Info
Gavi, the Vaccine Alliance (Gavi)
EU Transparency Register
078294941111-90 First registered on 27 Jan 2021
Goals / Remit
Gavi’s mission is: “Saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries."
The Gavi Alliance promotes health by: (i) providing vaccines and the means to deliver such vaccines to people in the poorest countries; (ii) facilitating the research and development of vaccines of primary interest to the developing world; and (iii) providing support in connection with achieving the foregoing purposes by helping to strengthen health care systems and civil societies supporting such purposes in the developing world.
Gavi co-led COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator.Main EU files targeted
European Consensus on Development
EU Strategy on Africa
EU Global Health Strategy
Global Gateway
MAV+ Initiative
Global COVID-19 vaccine responseAddress
Head Office
Gavi, the Vaccine Alliance Chemin du Pommier, 40
Grand-Saconnex 1218
SWITZERLANDEU Office
Gavi, the Vaccine Alliance Chemin du Pommier, 40
Grand-Saconnex 1218
SWITZERLANDWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 75% 1 25% 1 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Other organisations, public or mixed entities
-
Networking
Affiliation
The Board is comprised of 18 “representative” seats, 9 seats for independent or “unaffiliated” individuals and one seat for Gavi's CEO. The Board’s representative seats ensure that institutions and constituencies can provide formal input into the development of all Gavi’s policies and the management of its operations.
UNICEF, WHO, the World Bank and the Bill & Melinda Gates Foundation hold permanent seats on the Board. Constituency representatives serve on a time-limited basis. Board members include representation from donor governments, implementing country governments, civil society organisations and the vaccine industry.
Independent Board members are private individuals with no professional connection to Gavi’s work. They bring independent and balanced scrutiny to all of the Board’s deliberations. These individuals also provide expertise in a number of critical areas such as investment, auditing and fundraising.Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
Type Name Amount Grant EC grant 30,000,000€ Intermediaries for closed year
Name Amount valentina barbagallo - valia bv 25,000€ - 49,999€ Intermediaries for current year
Name valia bv Closed year Costs
100,000€ - 199,999€
Other financial info
Contributions reflected in the closed financial year only include contributions that were recognized in that year following the expense verification audit (and not cash received). Financial statements for the year 2023 are not yet finalized as of February 12, 2024.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Global Gateway Summit
Global Health Policy Forum
Regular calls with DG INTPA (donor calls)Other activities
None declared
Meetings
Meetings
29 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 16 Sep 2024 Location Brussels Subject Follow up call DG Directorate-General for International Partnerships Attending - Koen Doens (Director-General)
-
Date 11 Sep 2024 Location Brussels Subject Vaccine DG Directorate-General for International Partnerships Attending - Koen Doens (Director-General)
-
Date 18 Jan 2024 Location Davos Subject Global vaccination trends; climate change and health Cabinet Cabinet of Commissioner Wopke Hoekstra Attending - Wopke Hoekstra (Commissioner)
-
Date 16 May 2023 Location Brussels Subject Exchange of views on the partnership between EU and GAVI Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 21 Apr 2023 Location Brussels Subject Global Health architecture & vaccine donations Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Ines Prainsack (Cabinet member)
- Giorgios Rossides (Cabinet member)
- Stella Kyriakides (Commissioner)
-
Date 24 May 2022 Location Videoconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 11 May 2022 Location Teleconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 01 Apr 2022 Location WEBEX Subject Exchange on the current state of play for the COVAX AMC, the needs ahead, and our work with the Commission to continue to strengthen the global pandemic response Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 29 Mar 2022 Location Videoconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 23 Mar 2022 Location WEBEX Subject Update on COVAX & donations Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 18 Mar 2022 Location Teleconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 18 Feb 2022 Location Brussels Subject Global COVID-19 vaccination Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Jutta Urpilainen (Commissioner)
-
Date 11 Feb 2022 Location Brussels Subject Update of COVAX progress, the achievements of Team Europe support, and exchange on what lies ahead Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 11 Feb 2022 Location Brussels - L-15 Subject Meeting with Managing Director of Resource Mobilisation, Marie-Ange Saraka-Yao - Update on progress and achievements of Team Europe support DG Health Emergency Preparedness and Response Authority Attending - Pierre Delsaux (Director-General)
-
Date 11 Jan 2022 Location Videoconference Subject State of play in COVID-19 vaccine deliveries and the future cooperation in 2022 Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Jutta Urpilainen (Commissioner)
-
Date 22 Dec 2021 Location Videoconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 06 Dec 2021 Location Webex meeting Subject Exchanges with GAVI on COVAX, vaccine equity and ACT-A. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Ines Prainsack (Cabinet member)
-
Date 29 Nov 2021 Location Videoconference Subject Exchange of views on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 15 Oct 2021 Location Brussels Subject Meeting with Chair of GAVI Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 05 Sep 2021 Location Virtual meeting Subject Exchanges with GAVI on COVAX, vaccine equity and ACT-A. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 02 Mar 2021 Location Teleconference Subject COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 25 Feb 2021 Location Videoconference Subject Discussion on COVAX and access to vaccines Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Jutta Urpilainen (Commissioner)
-
Date 25 Feb 2021 Location Online Subject Exchange of good communication practices. DG Communication Attending - Pia Ahrenkilde Hansen (Director-General)
-
Date 22 Feb 2021 Location Virtual meeting Subject Exchange on COVAX and the EU vaccine sharing mechanism. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 18 Feb 2021 Location Teleconference Subject Covax Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 01 Feb 2021 Location Teleconference Subject COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 22 Dec 2020 Location Teleconference Subject Update on COVAX Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Renaud Savignat (Cabinet member)
-
Date 09 Apr 2020 Location Teleconference Subject COVID-19 Cabinet Cabinet of Commissioner Jutta Urpilainen Portfolio International Partnerships Attending - Jutta Urpilainen (Commissioner)
-
Date 31 Mar 2020 Location Webex, Online Subject COVID-19 and access to Vaccines Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Roberto Reig Rodrigo (Cabinet member)